Status:
COMPLETED
Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients
Lead Sponsor:
Instituto Nacional de Cancerologia de Mexico
Conditions:
Phase II Clinical Trial
Ninety-six Histologically Confirmed NSCLC Patients With BM
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
Brief Summary
Background: Whole-brain radiotherapy (WBRT) is the standard treatment for multiple brain metastases (BM), in NSCLC patients who are not candidates for treatment with stereotactic radiation body therap...
Detailed Description
Non-small cell Lung cancer (NSCLC) is the most frequent type of lung cancer worldwide. Brain metastases (BM) are the most frequent neurological complications related to NSCLC and it is estimated that ...
Eligibility Criteria
Inclusion
- Patients with histologically confirmed NSCLC with documented BM (defined as the presence of one or more intra-axial enhancing lesions on gadolinium-enhanced brain magnetic resonance imaging (MRI)
Exclusion
- Candidate patients who underwent radiosurgery or surgery resection
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT04338867
Start Date
March 1 2020
End Date
March 1 2020
Last Update
April 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute of Mexico
Mexico City, Mexico City, Mexico, 14080